BAJAJ BROKING

Notification
No new Notification messages
Hexaware Technologies IPO is Open!
Apply for the Hexaware Technologies IPO through UPI in just minutes.
Q3 FY'25 Results of Top Companies!
From Reliance Industries to TCS to HDFC Bank, check out the latest quarterly results with financial highlights, key performance metrics, and more!
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
NSE BSE
vivanza biosciences limited stock

Vivanza Biosciences Limited Share Price

2.43 0.11 (4.74%)
14 Feb 2025 | 03:30 PM Pharmaceuticals NSE: VIVANZA

Vivanza Biosciences Limited Share Price Update

As of the latest trading session, Vivanza Biosciences Limited share price is currently at 2.43, which is up by 0.11 from its previous closing. Today, the stock has fluctuated between 2.23 and 2.43. Over the past year, Vivanza Biosciences Limited has achieved a return of -71.74 %. In the last month alone, the return has been -28.52 %. Read More...

Vivanza Biosciences Limited Performance

Day Range

Low2.23 High2.43
2.43

52 Week Range

Low 2.00 High 9.54
2.43

Vivanza Biosciences Limited Share Price

530057

VIVANZA

img img img img
No Data Available

Open Price

2.23

Prev. Close

2.32

Volume (Shares)

78153.00

Total traded value

1.87

Upper Circuit

2.55

Lower Circuit

2.31

Note: The current prices & values are delayed, Login to your account for live updates.

Vivanza Biosciences Limited Fundamentals


(Standalone)

Market Cap (Cr) 9.72
PE Ratio (TTM) -81.00
Book Value / Share 1.23
Beta 0.26
ROE 7.02%
EPS (TTM) 0.00
Dividend Yield 0.00%
Net Profit Qtr (Cr) 0.04

Vivanza Biosciences Limited Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars DEC 2024 (Values in Cr)
Revenue 0.76
Operating Expense 0.74
Net Profit 0.04
Net Profit Margin (%) 5.26
Earnings Per Share (EPS) 0.01
EBITDA 0.13
Effective Tax Rate (%) 0.00
Particulars SEP 2024 (Values in Cr)
Revenue 1.58
Operating Expense 1.58
Net Profit 0.01
Net Profit Margin (%) 0.63
Earnings Per Share (EPS) 0.00
EBITDA 0.09
Effective Tax Rate (%) 0.00
Particulars JUN 2024 (Values in Cr)
Revenue 0.43
Operating Expense 0.20
Net Profit 0.23
Net Profit Margin (%) 53.48
Earnings Per Share (EPS) 0.06
EBITDA 0.32
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Revenue 2.30
Operating Expense 2.53
Net Profit -0.38
Net Profit Margin (%) -16.52
Earnings Per Share (EPS) -0.09
EBITDA -0.17
Effective Tax Rate (%) -40.74
Particulars DEC 2023 (Values in Cr)
Revenue 3.37
Operating Expense 3.20
Net Profit 0.18
Net Profit Margin (%) 5.34
Earnings Per Share (EPS) 0.05
EBITDA 0.28
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Revenue 14.41
Operating Expense 14.04
Net Profit 0.32
Net Profit Margin (%) 2.22
Earnings Per Share (EPS) 0.08
EBITDA 0.85
Effective Tax Rate (%) 25.58
Particulars MAR 2023 (Values in Cr)
Revenue 14.21
Operating Expense 13.91
Net Profit 0.57
Net Profit Margin (%) 4.01
Earnings Per Share (EPS) 1.42
EBITDA 1.10
Effective Tax Rate (%) 17.39
Particulars MAR 2022 (Values in Cr)
Revenue 9.15
Operating Expense 9.52
Net Profit 0.46
Net Profit Margin (%) 5.02
Earnings Per Share (EPS) 1.16
EBITDA 0.88
Effective Tax Rate (%) 0.00
Particulars MAR 2021 (Values in Cr)
Revenue 9.22
Operating Expense 9.58
Net Profit 0.10
Net Profit Margin (%) 1.08
Earnings Per Share (EPS) 0.25
EBITDA 0.63
Effective Tax Rate (%) 33.33
Particulars MAR 2020 (Values in Cr)
Revenue 9.43
Operating Expense 10.17
Net Profit -0.20
Net Profit Margin (%) -2.12
Earnings Per Share (EPS) -0.51
EBITDA 0.24
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Book Value / Share 1.16
ROE % 12.60
ROCE % 10.23
Total Debt to Total Equity 1.51
EBITDA Margin 4.06
Particulars MAR 2023 (Values in Cr)
Book Value / Share 1.02
ROE % 14.84
ROCE % 10.65
Total Debt to Total Equity 1.78
EBITDA Margin 6.46
Particulars MAR 2022 (Values in Cr)
Book Value / Share 8.73
ROE % 8.25
ROCE % 10.96
Total Debt to Total Equity 0.88
EBITDA Margin 7.40
Particulars MAR 2021 (Values in Cr)
Book Value / Share 7.90
ROE % 2.26
ROCE % 15.32
Total Debt to Total Equity 0.12
EBITDA Margin 6.07
Particulars MAR 2020 (Values in Cr)
Book Value / Share 7.71
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.29
EBITDA Margin 2.39
Particulars MAR 2024 (Values in Cr)
Book Value / Share 1.18
ROE % 7.02
ROCE % 8.98
Total Debt to Total Equity 1.08
EBITDA Margin 5.97
Particulars MAR 2023 (Values in Cr)
Book Value / Share 1.10
ROE % 13.57
ROCE % 11.56
Total Debt to Total Equity 1.33
EBITDA Margin 7.88
Particulars MAR 2022 (Values in Cr)
Book Value / Share 9.57
ROE % 11.50
ROCE % 14.13
Total Debt to Total Equity 0.64
EBITDA Margin 9.84
Particulars MAR 2021 (Values in Cr)
Book Value / Share 8.41
ROE % 2.75
ROCE % 16.25
Total Debt to Total Equity 0.05
EBITDA Margin 6.83
Particulars MAR 2020 (Values in Cr)
Book Value / Share 8.16
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.16
EBITDA Margin 2.55
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.16
Total Assets 19.50
Total Liabilities 19.50
Total Equity 4.63
Share Outstanding 40000000
Price to Book Ratio 5.75
Return on Assets (%) 2.80
Return on Capital (%) 5.58
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.14
Total Assets 22.47
Total Liabilities 22.47
Total Equity 4.09
Share Outstanding 40000000
Price to Book Ratio 17.09
Return on Assets (%) 2.66
Return on Capital (%) 4.95
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.05
Total Assets 15.56
Total Liabilities 15.56
Total Equity 3.49
Share Outstanding 4000000
Price to Book Ratio 19.71
Return on Assets (%) 2.13
Return on Capital (%) 3.7
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments -3.09
Total Assets 8.44
Total Liabilities 8.44
Total Equity 3.15
Share Outstanding 4000000
Price to Book Ratio 15.53
Return on Assets (%) 0.89
Return on Capital (%) 2.14
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments -2.77
Total Assets 12.35
Total Liabilities 12.35
Total Equity 3.08
Share Outstanding 4000000
Price to Book Ratio 0.00
Return on Assets (%) -1.66
Return on Capital (%) -5.93
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.09
Total Assets 16.87
Total Liabilities 16.87
Total Equity 4.71
Share Outstanding 40000000
Price to Book Ratio 5.75
Return on Assets (%) 1.88
Return on Capital (%) 3.98
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.10
Total Assets 20.44
Total Liabilities 20.44
Total Equity 4.39
Share Outstanding 40000000
Price to Book Ratio 17.09
Return on Assets (%) 2.78
Return on Capital (%) 5.19
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.01
Total Assets 14.20
Total Liabilities 14.20
Total Equity 3.82
Share Outstanding 4000000
Price to Book Ratio 19.71
Return on Assets (%) 3.26
Return on Capital (%) 5.62
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments -3.11
Total Assets 7.93
Total Liabilities 7.93
Total Equity 3.36
Share Outstanding 4000000
Price to Book Ratio 15.53
Return on Assets (%) 1.25
Return on Capital (%) 2.82
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments -2.81
Total Assets 12.27
Total Liabilities 12.27
Total Equity 3.26
Share Outstanding 4000000
Price to Book Ratio 0.00
Return on Assets (%) -1.65
Return on Capital (%) -5.92
Particulars MAR 2024 (Values in Cr)
Net Income 0.69
Cash from Operations 2.19
Cash from Investing -0.03
Cash from Financing -1.98
Net change in Cash 0.02
Free Cash Flow 2.23
Particulars MAR 2023 (Values in Cr)
Net Income 0.71
Cash from Operations -0.82
Cash from Investing 0.00
Cash from Financing 1.03
Net change in Cash 0.08
Free Cash Flow -0.82
Particulars MAR 2022 (Values in Cr)
Net Income 0.33
Cash from Operations 2.46
Cash from Investing 0.00
Cash from Financing -2.47
Net change in Cash -0.01
Free Cash Flow 2.46
Particulars MAR 2021 (Values in Cr)
Net Income 0.14
Cash from Operations -3.02
Cash from Investing -0.02
Cash from Financing 2.79
Net change in Cash -0.30
Free Cash Flow -3.00
Particulars MAR 2020 (Values in Cr)
Net Income -0.20
Cash from Operations 2.97
Cash from Investing 0.00
Cash from Financing -2.75
Net change in Cash 0.22
Free Cash Flow 2.97
Particulars MAR 2024 (Values in Cr)
Net Income 0.42
Cash from Operations 1.89
Cash from Investing -0.03
Cash from Financing -1.76
Net change in Cash -0.01
Free Cash Flow 1.93
Particulars MAR 2023 (Values in Cr)
Net Income 0.68
Cash from Operations 0.27
Cash from Investing 0.00
Cash from Financing -0.07
Net change in Cash 0.08
Free Cash Flow 0.27
Particulars MAR 2022 (Values in Cr)
Net Income 0.46
Cash from Operations -0.67
Cash from Investing 0.00
Cash from Financing 0.65
Net change in Cash -0.02
Free Cash Flow -0.67
Particulars MAR 2021 (Values in Cr)
Net Income 0.14
Cash from Operations -3.02
Cash from Investing -0.02
Cash from Financing 2.79
Net change in Cash -0.30
Free Cash Flow -3.00
Particulars MAR 2020 (Values in Cr)
Net Income -0.20
Cash from Operations 2.79
Cash from Investing 0.00
Cash from Financing -2.58
Net change in Cash 0.21
Free Cash Flow 2.79
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 48.41 27.82 2.64 370.98 39.20 / 77.70
BLISS GVS PHARMA LTD 132.25 17.33 1.37 1393.52 92.25 / 184.95
CIPLA LTD 1459.05 23.62 4.15 117834.93 1317.60 / 1702.00
FERMENTA BIOTECH LIMITED 298.95 24.77 3.03 879.84 145.00 / 449.00
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 48.41 42.10 8.23 370.98 39.20 / 77.70
AMRUTAJAN HEALTH LTD 612.45 35.90 5.94 1770.63 591.10 / 861.40
ASTRAZENECA PHARMA IND LT 7096.35 105.84 26.11 17740.88 4050.15 / 8139.85
BLISS GVS PHARMA LTD 132.25 17.18 1.36 1393.52 92.25 / 184.95

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 2.30
  • 26 Days 2.80
  • 10 Days 2.40
  • 50 Days 3.10
  • 12 Days 2.50
  • 100 Days 3.60
  • 20 Days 2.70
  • 200 Days 4.70
2.30
PIVOT
First Resistance 2.34
Second Resistance 2.37
Third Resistance 2.41
First Support 2.27
Second Support 2.23
Third Support 2.20
RSI 34.75
MACD -0.29
Commodity Channel Index (CCI) -72.76
ADX 91.13
Williams % R -64.17

Over 1 Month

down

-28.52

Over 3 Months

down

-41.72

Over 6 Months

down

-40.14

Over 1 Year

down

-71.74

Over 3 Years

down

-45.84

Over 5 Years

down

14.21

Vivanza Biosciences Limited Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

Vivanza Biosciences Limited Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Public
79.97
Promoter Holdings
20.01
FII
0.0
DII
0.0
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Parth Hemant Parikh Shareholding of Promoter and Promoter Group 7907622.0 19.77
Ashoka Metcast Limited Public Shareholding 1539259.0 3.85
Vishal Chinubhai Suthar Huf(huf) Public Shareholding 1139679.0 2.85
Swati Vishal Suthar Public Shareholding 612397.0 1.53
Ammishi M Desai Public Shareholding 600000.0 1.5
Kalpesh Vithaldas Rami Public Shareholding 424313.0 1.06
Hemant Amrish Parikh Shareholding of Promoter and Promoter Group 100211.0 0.25

Vivanza Biosciences Limited

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date
2023-03-24 10.0 1.0 2023-03-24

Learn More About Stocks

About Vivanza Biosciences Limited

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by Vivanza Biosciences Limited

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Vivanza Biosciences Ltd?

Answer Field

The share price of Vivanza Biosciences Ltd for NSE is ₹ 0.00 and for BSE is ₹ 2.43.

What is the Market Cap of Vivanza Biosciences Ltd?

Answer Field

The market cap of Vivanza Biosciences Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 9.70 Cr. as of now.

What is the 52 Week High and Low of Vivanza Biosciences Ltd?

Answer Field

The 52 Week High and Low of Vivanza Biosciences Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 9.54 and ₹ 2.00.

How to Buy Vivanza Biosciences Ltd share?

Answer Field

You can trade in Vivanza Biosciences Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Vivanza Biosciences Ltd?

Answer Field

The 1 year returns on the stock has been -71.74%.

What is the Current Share Price of Vivanza Biosciences Ltd?

Answer Field

Vivanza Biosciences Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 2.43 as on 14 Feb 2025 | 03:30 PM.

What is the Market Cap of Vivanza Biosciences Ltd Share?

Answer Field

The market cap of Vivanza Biosciences Ltd for NSE ₹ 0.0 & for BSE ₹ 9.70 as on 14 Feb 2025 | 03:30 PM.

What is the P/E Ratio of Vivanza Biosciences Ltd Share?

Answer Field

As on 14 Feb 2025 | 03:30 PM the price-to-earnings (PE) ratio for Vivanza Biosciences Ltd share is -81.00.

What is the PB ratio of Vivanza Biosciences Ltd Share?

Answer Field

As on 14 Feb 2025 | 03:30 PM, the price-to-book (PB) ratio for Vivanza Biosciences Ltd share is 1.23.

How to Buy Vivanza Biosciences Ltd Share?

Answer Field

You can trade in Vivanza Biosciences Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Vivanza Biosciences Ltd Share on Bajaj Broking App?

Answer Field

To buy Vivanza Biosciences Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Vivanza Biosciences Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

9 Lacs+ Users

icon-with-text

4.1+ App Rating

icon-with-text

4 Languages

icon-with-text

₹5100+ Cr MTF Book

icon-with-text
loader